Tissue Engineering and Regenerative Medicine in Pediatric Urology: Urethral and Urinary Bladder Reconstruction

Martina Casarin1, Alessandro Morlacco1, Fabrizio Dal Moro1

  • 1Department of Surgery, Oncology and Gastroenterology, Giustiniani 2, 35128 Padua, Italy.

Insights

Tissue engineering offers promising solutions for pediatric urology conditions like hypospadias and neurogenic bladder. This review explores biomaterials and strategies for urethral and bladder reconstruction, focusing on tissue regeneration for better patient outcomes.

Area of Science:

  • Regenerative Medicine
  • Pediatric Urology
  • Biomaterials Science

Background:

  • Congenital pediatric urologic conditions like hypospadias and neurogenic bladder require surgical correction.
  • Current gold-standard surgeries (urethroplasty, enterocystoplasty) have significant complication rates.
  • Limited autologous tissue availability poses a challenge for reconstructive procedures.

Purpose of the Study:

  • To review tissue engineering strategies for urethral and urinary bladder reconstruction in pediatric patients.
  • To evaluate biomaterials and regenerative approaches for congenital urologic defects.
  • To highlight critical features for successful pediatric urinary tissue engineering.

Main Methods:

  • Comprehensive literature review of studies on urethral and bladder reconstruction using tissue engineering.
  • Analysis of biomaterials tested in animal models and human patients.
  • Evaluation of tissue regeneration capabilities based on cell seeding and growth factor incorporation in scaffolds.

Main Results:

  • Various biomaterials have been tested for urethral and bladder reconstruction in pediatric models.
  • Scaffold properties, cell types, and growth factors influence tissue regeneration potential.
  • Successful integration and functional recovery are key indicators of efficacy.

Conclusions:

  • Tissue engineering holds significant potential to overcome limitations of current surgical treatments for pediatric urologic conditions.
  • Optimizing scaffold design, cell sourcing, and growth factor delivery is crucial for advancing regenerative strategies.
  • Further research focusing on pediatric-specific needs is essential for clinical translation.